This is a routine director sale of shares acquired through vesting. No material signal for the stock. Monitor for any larger insider sales or changes in insider filing patterns ahead of the next earnings report.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Oct 26 $242.95entry
- T+1 · 21d ago −0.16%α −0.72% · $242.56
- T+5 · 15d ago +3.65%α +4.91% · $251.82
- T+15 · todayOpen
- T+20 · in 6d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Gary M. Pfeiffer filed a Form 144 notice of intent to sell 1,203 shares of Quest Diagnostics common stock, valued at approximately $292,329 based on the filing. The shares were acquired through restricted stock vesting on May 15, 2026, and the sale is planned for the NYSE. This is a small, routine sale by a director relative to the company's $26.9B market cap.
Key Facts
- Director Gary M. Pfeiffer filed Form 144 to sell 1,203 shares of Quest Diagnostics common stock.
- The approximate market value of the proposed sale is $292,329.
- Shares were acquired via restricted stock vesting on May 15, 2026, as compensation.
- The sale is planned for execution on the NYSE on October 26, 2026.
- The proposed sale represents a tiny fraction of the company's $26.9B market cap.
Financial Impact
Proposed sale of 1,203 shares valued at ~$292,329, negligible relative to $26.9B market cap.
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed.
- No other insider selling context provided to assess pattern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007482 |
| Document: 0001959173-26-007482-index.html | 0001959173-26-007482 |
| Document: 0001959173-26-007482.txt | 0001959173-26-007482 |
Track record
24 reports on DGX
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $262.21 +1.46% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
- Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $262.21 +2.57% settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
- Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers